SCHEMBL17242546

SCHEMBL17242546

Cn1c(=O)n(Cc2ccc(Cl)c(Cl)c2)c(=O)c2ccc(F)cc21.O=c1[nH]c2cc(F)ccc2c(=O)n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 3/20 0.44
CACNA1G O43497 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CCR2 P41597 1/20 0.42
KMT2A Q03164 2/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.41
STAT6 P42226 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
FEN1 P39748 1/20 0.40
SRC P12931 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17241627 0.90 SMN1; SMN2 (0.50) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL17242694 0.89 KDM4E (0.50) HTR3ACACNA1GSMN1; SMN2CCR2KMT2A
SCHEMBL17242750 0.86 KDM4E (0.58) HTR3ACACNA1GSMN1; SMN2KMT2AMAPK1
SCHEMBL17241982 0.81 MAPT (0.48) KMT2AMAPK1MAPTLMNASTAT6
SCHEMBL17241606 0.77 KDM4E (0.55) HTR3ACACNA1GSMN1; SMN2KMT2AMAPT
SCHEMBL17241577 0.76 CCR2 (0.53) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL17242542 0.75 CA12 (0.53) SMN1; SMN2CCR2KDM4EALDH1A1HPGD
SCHEMBL17242598 0.74 KDM4E (0.70) HTR3ACACNA1GSMN1; SMN2KMT2AMAPT
SCHEMBL17241490 0.74 P2RX3 (0.46) MAPTGRIN1GRIN2BTP53
SCHEMBL17241863 0.74 MAPT (0.54) SMN1; SMN2KMT2AMAPK1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3140301-A1 PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES Orion Corporation (FI) 2017-03-15 EP disclosed
WO-2015169999-A1 PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES ORION CORPORATION (FI) 2015-11-12 WO disclosed